NR1H4 and hyperlipidemia: The NR1H4 gene encodes the farnesoid X receptor (FXR), and its activation may have been involved in the reduction of liver steatosis and hyperlipidemia, through the suppression of de novo lipogenesis and the promotion of triglycerides oxidation and clearance.